Mechanistically, IGFBP2-regulated neuropeptides growth hormone receptor (GHR) and recombinant natriuretic peptide receptor 2 (NPR2) affect SFs, thereby promoting RA progression (95). The gene discussed is IGFBP2; the disease is rheumatoid arthritis.